# Jade Biosciences, Inc.: Form SCHEDULE 13D/A, filed Mar 5, 2026

- Company: [Jade Biosciences, Inc.](/companies/jbio.md) (CIK 1798749)
- Form: SCHEDULE 13D/A
- Filed: 2026-03-05
- Accepted by EDGAR: Mar 5, 2026, 06:04 ET
- Period: not reported
- Accession: 0001104659-26-023732
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1798749/000110465926023732/xslSCHEDULE_13D_X01/primary_doc.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1798749/000110465926023732/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1798749/000110465926023732/xslSCHEDULE_13D_X01/primary_doc.xml

Filed Mar 5, 2026.
Source: SEC EDGAR, the filing index for accession 0001104659-26-023732. Last ingested by Listed: Oct 24, 2026, 15:07 ET. No prices; not investment advice.